Prof. Dr. med. Kai-Uwe Eckardt

Department of Medicine 4 – Nephrology and Hypertension Lehrstuhl für Innere Medizin IV

High oxalate concentrations correlate with increased risk for sudden cardiac death in dialysis patients (2021) Pfau A, Ermer T, Coca SG, Tio MC, Genser B, Reichel M, Finkelstein FO, et al. Journal article Self-Reported Medication Use and Urinary Drug Metabolites in the German Chronic Kidney Disease (GCKD) Study (2021) Kotsis F, Schultheiss UT, Wuttke M, Schlosser P, Mielke J, Becker MS, Oefner PJ, et al. Journal article Association of the metabolic syndrome with mortality and major adverse cardiac events: A large chronic kidney disease cohort (2021) Pammer LM, Lamina C, Schultheiss UT, Kotsis F, Kollerits B, Stockmann H, Lipovsek J, et al. Journal article Frequent LPA KIV-2 Variants Lower Lipoprotein(a) Concentrations and Protect Against Coronary Artery Disease (2021) Schachtl-Riess JF, Kheirkhah A, Grüneis R, Di Maio S, Schoenherr S, Streiter G, Losso JL, et al. Journal article APOLIPOPROTEIN A-IV CONCENTRATIONS AND CLINICAL OUTCOMES IN CHRONIC KIDNEY DISEASE PATIENTS: RESULTS FROM THE GERMAN CHRONIC KIDNEY DISEASE (GCKD) STUDY (2021) Schwaiger JP, Kollerits B, Steinbrenner I, Weissensteiner H, Schoenherr S, Forer L, Kotsis F, et al. Conference contribution HIGHLY FREQUENT VARIANTS HIDDEN IN THE KIV-2 REGION OF LPA REGULATE LIPOPROTEIN(A) CONCENTRATIONS AND LOWER CORONARY ARTERY DISEASE RISK (2021) Schachtl-Riess JF, Kheirkhah A, Gruneis R, Di Maio S, Schoenherr S, Streiter G, Losso JL, et al. Conference contribution STRONG ASSOCIATION BETWEEN SERUM PCSK9 AND CARDIOVASCULAR DISEASE IN PATIENTS WITH MODERATE CHRONIC KIDNEY DISEASES THE GCKD STUDY (2021) Kheirkhah A, Lamina C, Kollerits B, Schachtl-Riess JF, Schultheiss UT, Forer L, Sekula P, et al. Conference contribution URINE METABOLITE LEVELS OF CKD PATIENTS ARE ASSOCIATED WITH ADVERSE KIDNEY OUTCOMES AND MORTALITY (2021) Steinbrenner I, Schultheiss UT, Kotsis FK, Schlosser P, Stockmann H, Mohney RP, Schmid M, et al. Conference contribution OSTEOPONTIN AND ITS ASSOCIATION WITH ADVERSE EVENTS IN THE GERMAN CHRONIC KIDNEY DISEASE STUDY (2021) Steinbrenner I, Cheng Y, Nadal J, Schmid M, Kotsis FK, Meiselbach H, Schneider M, et al. Conference contribution SELF-REPORTED MEDICATION USE AND URINARY DRUG METABOLITES IN THE GERMAN CHRONIC KIDNEY DISEASE (GCKD) STUDY: A PHARMACOMETABOLOMIC APPROACH (2021) Kotsis FK, Schultheiss UT, Wuttke M, Schlosser P, Oefner P, Mohney RP, Eckardt KU, et al. Conference contribution